March 05, 2018

Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial

In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.

Read the full article in The American of Tropical Medicine and Hygiene.

  • Commentary
    • The Interpreter
    • March 25, 2025
    Awful but Lawful: China’s Australia Flotilla

    As such, this was not a demonstration of Chinese freedom of navigation. It was a show of force....

    By Tom Shugart

  • Reports
    • March 13, 2025
    Safe and Effective

    The promise of artificial intelligence (AI) and autonomy to change the character of war inches closer to reality...

    By Josh Wallin

  • Commentary
    • March 13, 2025
    Sharper: Military Artificial Intelligence

    Since the atomic bomb, no technology has the potential to be as disruptive to warfare as artificial intelligence (AI). AI could deliver instant targeting solutions, develop hi...

    By Charles Horn

  • Commentary
    • Foreign Affairs
    • March 10, 2025
    America’s Eroding Airpower

    To have a chance at success, the United States would need more low-end drones and missiles that can provide it with mass....

    By Stacie Pettyjohn

View All Reports View All Articles & Multimedia